Bioxyne Ltd Capital Reinvestment Ratio
Bioxyne Ltd capital reinvestment ratio. Bioxyne Ltd (BXN) has a Capital Reinvestment Ratio of 0.33x as of June 2025, meaning it reinvests 0% of its operating cash flow (AU$3.32 Million) in capital expenditures (AU$1.11 Million). Check Bioxyne Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Bioxyne Ltd (2014–2025)
Capital reinvestment ratio of Bioxyne Ltd from 2014 to 2025. This chart tracks Bioxyne Ltd's Capital Reinvestment Ratio across 5 annual periods. Also explore BXN shareholders equity momentum to track the company's year-over-year net asset growth rate.
Bioxyne Ltd Capital Reinvestment Ratio by Year (2014–2025)
Bioxyne Ltd capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see Bioxyne Ltd (BXN) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | AU$6.28 Million | AU$2.41 Million | ▼ -39.3% |
| 2021 | 0.63x | AU$53.13K | AU$33.66K | ▼ -9.2% |
| 2020 | 0.70x | AU$48.25K | AU$33.66K | ▲ +6108.8% |
| 2016 | 0.01x | AU$348.85K | AU$3.92K | ▲ +73.9% |
| 2014 | 0.01x | AU$606.76K | AU$3.92K | — |